This compound is a spirocyclic heterocyclic molecule containing a tetrazatricyclic core with a methylsulfanyl substituent and a cyclohexane ring. It is characterized by a combination of aromatic rings, an amide group, and heterocyclic structural elements.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2170747-00-7
2-Amino-3-fluoropyridine
n.a
5-Methoxyresorcinol
n.a
SODIUM (+)-10-CAMPHORSULFONATE
n.a
2,3,4,5,6,7-Hexamethyl-1H-indene
n.a
Trilaciclib Impurity 36
pharmaceutical intermediate synthesis
Trilaciclib Impurity 3
Pharmaceutical impurity reference standard
Tert-butyl 4-methylsulfanyl-10-oxospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
4-methylsulfanylspiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
MORDOLIVMBQSKA-UHFFFAOYSA-N
CSC1=NC=C2C=C3C(=O)NCC4(N3C2=N1)CCCCC4
—